Canada markets open in 6 hours 18 minutes

TFF Pharmaceuticals, Inc. (0K3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.48000.0000 (0.00%)
As of 09:16AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 116.14M
Enterprise Value 90.74M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.39
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.82

Trading Information

Stock Price History

Beta (5Y Monthly) 2.13
52-Week Change 3-45.87%
S&P500 52-Week Change 3-0.65%
52 Week High 39.7500
52 Week Low 33.7600
50-Day Moving Average 35.3186
200-Day Moving Average 36.1446

Share Statistics

Avg Vol (3 month) 323
Avg Vol (10 day) 3N/A
Shares Outstanding 525.37M
Implied Shares Outstanding 6N/A
Float 821.6M
% Held by Insiders 114.85%
% Held by Institutions 117.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Dec 31, 2021


Profit Margin 0.00%
Operating Margin (ttm)-36,055.24%

Management Effectiveness

Return on Assets (ttm)-50.07%
Return on Equity (ttm)-81.60%

Income Statement

Revenue (ttm)88.16k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-21.21M
EBITDA -31.68M
Net Income Avi to Common (ttm)-31.04M
Diluted EPS (ttm)-1.2020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.79M
Total Cash Per Share (mrq)1.33
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.81
Book Value Per Share (mrq)1.53

Cash Flow Statement

Operating Cash Flow (ttm)-29.56M
Levered Free Cash Flow (ttm)-19.22M